PulseAugur
EN
LIVE 02:10:39

Shark-derived VNAR molecules show promise for advanced antibody therapies

Scientists are exploring the potential of tiny VNAR molecules derived from sharks for developing next-generation antibody therapies. These shark-derived molecules are noted for their exceptional stability and ability to access hard-to-reach molecular sites. Researchers are investigating their application in treating various conditions, including cancer, and for use in diagnostics and drug delivery, particularly across the blood-brain barrier. AI

RANK_REASON The item discusses scientific research into novel therapeutic molecules derived from a biological source. [lever_c_demoted from research: ic=1 ai=0.1]

Read on Forbes — Innovation →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Shark-derived VNAR molecules show promise for advanced antibody therapies

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Tool
The item discusses scientific research into novel therapeutic molecules derived from a biological source. [lever_c_demoted from research: ic=1 ai=0.1]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Low
Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
Story freshness
5 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. Forbes — Innovation TIER_1 English(EN) · Melissa Cristina Márquez, Contributor ·

    Why Scientists Are Turning To Sharks For The Next Generation Of Antibody Therapies

    Tiny VNAR molecules from sharks are remarkably stable, can squeeze into molecular hiding places larger antibodies cannot reach and are now being tested for everything from cancer therapies to diagnostics and drug delivery across the blood-brain barrier. The challenge? Turning an …